New Releases from NCBI BookshelfFilgotinib for treating moderately to severely active ulcerative colitis.Filgotinib for treating moderately to severely active ulcerative colitis.
Post Content
Post Content
This volume of the IARC Monographs provides evaluations of the carcinogenicity of two agents, perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid
Post Content